U.T. MD Anderson Cancer Center, Investigational Pharmacy Services - Unit 376 — Houston, Texas

U.T. MD Anderson Cancer Center, Investigational Pharmacy Services - Unit 376 is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

U.T. MD Anderson Cancer Center, Investigational Pharmacy Services - Unit 376 has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Early Breast Cancer, Breast Cancer.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for U.T. MD Anderson Cancer Center, Investigational Pharmacy Services - Unit 376?

U.T. MD Anderson Cancer Center, Investigational Pharmacy Services - Unit 376 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has U.T. MD Anderson Cancer Center, Investigational Pharmacy Services - Unit 376 conducted?

U.T. MD Anderson Cancer Center, Investigational Pharmacy Services - Unit 376 has 2 clinical trials on record, with 1 currently active. Their work covers Early Breast Cancer, Breast Cancer.

Is U.T. MD Anderson Cancer Center, Investigational Pharmacy Services - Unit 376 accredited by Crixeo Health?

U.T. MD Anderson Cancer Center, Investigational Pharmacy Services - Unit 376 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about U.T. MD Anderson Cancer Center, Investigational Pharmacy Services - Unit 376?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.